Targeted Oncology21h
Fellow's Perspective: Patient Case of Newly Diagnosed Multiple Myeloma
In a discussion with Peers & Perspectives in Oncology, fellowship program director Marc J. Braunstein, MD, PhD, FACP, and ...
Targeted Oncology6h
Advancements in CLL: CAR T, BTK Inhibitors and Personalized Medicine
Cyrus M. Khan, MD, discussed recent advancements in CLL treatment, particularly the shift to nonchemotherapy options and the ...
Targeted Oncology21h
FDA OKs Study of Amezalpat in Frontline Liver Cancer
The FDA approved a phase 3 trial to assess amezalpat with the current standard of care in unresectable or metastatic ...
Targeted Oncology23h
Elraglusib Gains FDA Rare Pediatric Disease Designation in Ewing Sarcoma
Elraglusib is undergoing investigation in an open-label, multicenter, phase 1/2 trial for the treatment of patients with ...
Targeted Oncology21h
New Therapies Expand Options in Recurrent Small Cell Lung Cancer
Ariel Lopez-Chavez, MD, discusses the current approach to managing recurrent small cell lung cancer especially in patients who have progressed after first-line chemotherapy. Ariel Lopez-Chavez, MD, ...